drugset / Trial / NCT05369065
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NaParallel-groupDouble-blindTreatment
Summary
This study is to assess the safety and performance of the Neurotronic Infusion Catheter and ethanol denervation of renal and hepatic arteries for the treatment of patients with Type 2 Diabetes (T2DM), Hypertension and Obesity.
Timeline
- Start
- 2022-01-27
- Primary completion
- 2025-01
- Completion
- 2029-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcohol | Other / unclassified | — | — |